Clinical Trial

Examining the Effects of a Remote Pulmonary Rehabilitation Program in the Severe Asthma Population.

Study acronym: STAPLE
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 29, 2023 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a randomized control trial evaluating the effect of a novel mobile application-delivered pulmonary rehabilitation program in adult severe asthma patients. The intervention will include eight weeks of exercise videos that progress in difficulty, as well as asthma-specific educational content. The primary outcome measure is change in functional exercise capacity as measured by six-minute walk distance. Secondary outcome measures will include evaluation of overall feasibility, and change in CPET parameters such as VO2max. Change in asthma control questionnaire (ACQ), asthma quality of life questionnaire (AQLQ) and PRAISE self-efficacy score will also be evaluated.
Trial Details
NCT Number NCT06150300
Lead Sponsor University of Saskatchewan
Conditions Asthma
Enrollment 34 participants
Start Date 2024-01-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-11-29